Jun Wang
11PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 11, 2024
The efficacy and safety of a novel PD-1/CTLA-4 bispecific antibody cadonilimab (AK104) in advanced non-small cell lung cancer: A multicenter retrospective observational study.Hongxin Li, Wen Zhao, Chengming Li
|Mar 08, 2024
Histological sarcomatoid transformation in a lung adenocarcinoma patient following immune checkpoint blockade.Xiuju Liang, Yaping Guan, Baocheng Wang
|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.Gen Lin, Zhijie Wang, Qian Chu
|Nov 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.Dingzhi Huang, Gen Lin, Qian Chu
|Sep 07, 2023
Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real-world study.Baocheng Wang, Chen Zhong, Zijun Liao
|Jul 24, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.Jun Wang, Bicheng Zhang, Ling Peng
Pageof 2
